The 4 years’ NMIBC recurrence rates within a prospective, randomized-controlled clinical setting – NBI versus standard TURBT diagnostic accuracy and long-term evidence-based oncologic outcome
By: B. Geavlete, Bucharest (RO)
Session: Oral presentation of the 6 best abstracts Oral presentation of the 6 best abstracts
Location: Saturday, 10 November 2018, 12:00 - 12:30, Auditorium